Lipid-lowering agents for nephrotic syndrome: Cochrane systematic review
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Lipid-lowering Agents for Nephrotic Syndrome: Cochrane Systematic Review." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/437563/all/Wound‐care_teams_for_preventing_and_treating_pressure_ulcers_New. Accessed 25 April 2024.
Lipid-lowering agents for nephrotic syndrome: Cochrane systematic review. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/437563/all/Wound‐care_teams_for_preventing_and_treating_pressure_ulcers_New. Accessed April 25, 2024.
Lipid-lowering agents for nephrotic syndrome: Cochrane systematic review. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/437563/all/Wound‐care_teams_for_preventing_and_treating_pressure_ulcers_New
Lipid-lowering Agents for Nephrotic Syndrome: Cochrane Systematic Review [Internet]. In: Cochrane Abstracts. [cited 2024 April 25]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/437563/all/Wound‐care_teams_for_preventing_and_treating_pressure_ulcers_New.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Lipid-lowering agents for nephrotic syndrome: Cochrane systematic review
ID - 437563
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/437563/all/Wound‐care_teams_for_preventing_and_treating_pressure_ulcers_New
DB - Evidence Central
DP - Unbound Medicine
ER -